ArticleClinical kidney journal2025
Novel eGFR equations and cardiovascular outcomes in a multiethnic Asian cohort.
Article in Clinical kidney journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multi-Marker Detection of Diabetic Kidney Disease and Risk of Incident Diabetic Retinopathy in a Multi-Ethnic Asian Population.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Novel creatinine-based glomerular filtration rate (GFR) estimating equations were proposed for chronic kidney disease (CKD) evaluation but their comparative ability to predict mortality and cardiovascular events is less established. We compared four Chronic Kidney Disease Epidemiology Collaboration equations and three European Kidney Function Consortium (EKFC) equations in predicting risk for all-cause mortality and cardiovascular events in multiethnic Asians. Methods: We performed analysis of Singapore Epidemiology of Eye Diseases population-based cohort that recruited Chinese and Indian aged 40-80 years between 2007 and 2011. The outcomes of death and incident cardiovascular events were ascertained by data linkage with National Registry of Diseases Office until 31 March 2021. Using Cox proportional hazards model, we conducted multivariable regression analyses to evaluate the association of CKD and outcomes. C-statistic was performed to compare prediction performance of these equations. Results: During a mean follow-up of 11.3 ± 2.2 years, the all-cause mortality rate was 12.9% (743 of 5738 participants). When using Creat-ASR 2009, Creat-AS 2021, Cys 2012, Creat-cys 2021, EKFCcreat, EKFCcys and EKFCcreat-cys, mortality rates among those with CKD (eGFR <60 mL/min/1.73 m Conclusion: Creat-cys 2021 outperformed creatinine-based GFR equations and demonstrated comparable performance to Cys 2012, EKFCcys and EKFCcreat-cys in predicting all-cause mortality. For incident CVD, Creat-AS 2021 and EKFCcreat demonstrated performance comparable to that of Cys 2012, Creat-cys 2021, EKFCcys and EKFCcreat-cys, providing cost-effective and equally reliable alternatives in this multiethnic Asian population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.